Fundraising FoxAugmenix
1 known investors
Find your way into Augmenix
Sign up to see every warm intro you have to Augmenix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Augmenix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SpaceOAR Hydrogel is a polyethylene glycol-based hydrogel spacer used during prostate cancer radiation therapy to reduce urinary, sexual, and bowel side effects. It is a medical device offered to prostate cancer patients and their physicians in the United States.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries EJul 2016Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Augmenix do?
- SpaceOAR Hydrogel is a polyethylene glycol-based hydrogel spacer used during prostate cancer radiation therapy to reduce urinary, sexual, and bowel side effects. It is a medical device offered to prostate cancer patients and their physicians in the United States.
- Who are Augmenix's investors?
- Augmenix's investors include Excelestar Ventures.